Skip to main content
2025 Annual Meeting Main banner

    Greg A. Gerhardt, PhD (he/him/his)

    Professor of Neuroscience, Neurology and Neurosurgery
    University of Kentucky Medical Center
    Lexington, Kentucky, United States

    Greg Gerhardt, Ph.D. – Dr. Gerhardt is Professor (with tenure) of Neuroscience, Neurosurgery, Neurology, Psychiatry and Electrical Engineering at the University of Kentucky Health Sciences Center (UKHSC) in Lexington, KY. He has focused extensively on “bench-to-bedside” development of novel therapeutics and therapies for Parkinson’s disease. He has published over 360 peer-reviewed papers and >80 book chapters. He has had consistent funding from NIH, NSF, DARPA and private foundations for over 35 years. Dr. Gerhardt directed the Phase I clinical trial on glial cell-line derived neurotrophic factor (GDNF) for Parkinson’s disease, which was a joint effort with Amgen. He has also been involved with the preclinical and clinical development of numerous drugs and devices with major biotechnology and pharmaceutical companies. He is currently the Co-Director of the Neurorestoration Center, which was formed after his leadership of an NINDS Morris K. Udall Parkinson’s disease Research Center of excellence from 1999-2012. In his spare time he enjoys scuba diving, down-hill skiing, flying in vintage airplanes and rebuilding “muscle” cars.

    Presentation(s):